Ftse Mib
34.491,64
-0,15%
DAX
18.516,77
0,15%
S&P 500
5.360,79
0,26%
NASDAQ
17.192,53
0,35%
Bitcoin
67.800,00
-2,46%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Curagen Corp. (MM) (CRGN) Curagen Corp. (MM) (CRGN) Notizie

CRGN

Curagen Corp. (MM) (CRGN)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CRGN
DataOraFonteTitoloSimboloCompagnia
02/10/200912:02Edgar (US Regulatory)Current report filing (8-K)NASDAQ:CRGNCuragen Corp. (MM)
01/10/200922:28Edgar (US Regulatory)(25-NSE)NASDAQ:CRGNCuragen Corp. (MM)
01/10/200920:29Business WireCelldex Therapeutics Announces Completed Acquisition of CuraGen CorporationNASDAQ:CRGNCuragen Corp. (MM)
01/10/200900:00Business WireCelldex and CuraGen Stockholders Approve Acquisition of CuraGen CorporationNASDAQ:CRGNCuragen Corp. (MM)
25/09/200922:33Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CRGNCuragen Corp. (MM)
03/09/200912:01Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:CRGNCuragen Corp. (MM)
28/08/200923:27Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (DEFM14A)NASDAQ:CRGNCuragen Corp. (MM)
17/08/200922:50Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/A)NASDAQ:CRGNCuragen Corp. (MM)
05/08/200920:03Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:CRGNCuragen Corp. (MM)
31/07/200912:00PR Newswire (US)CuraGen Reports Second Quarter 2009 Financial ResultsNASDAQ:CRGN
22/06/200923:07Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:CRGNCuragen Corp. (MM)
19/06/200919:45Edgar (US Regulatory)Amended Annual Report (10-K/A)NASDAQ:CRGNCuragen Corp. (MM)
17/06/200912:30PR Newswire (US)CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Advanced Breast CancerNASDAQ:CRGNCuragen Corp. (MM)
10/06/200923:02Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:CRGNCuragen Corp. (MM)
09/06/200921:22Edgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:CRGNCuragen Corp. (MM)
03/06/200921:42Edgar (US Regulatory)Amended Current report filing (8-K/A)NASDAQ:CRGNCuragen Corp. (MM)
02/06/200912:30PR Newswire (US)CuraGen Updates CR011-vcMMAE Data at ASCONASDAQ:CRGNCuragen Corp. (MM)
29/05/200922:50Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:CRGNCuragen Corp. (MM)
29/05/200912:54Business WireCelldex Therapeutics, Inc. Enhances Precision Targeted Immunotherapy Platform with the Acquisition of CuraGen CorporationNASDAQ:CRGNCuragen Corp. (MM)
28/05/200912:30PR Newswire (US)CuraGen to Present CR011-vcMMAE Data at ASCONASDAQ:CRGNCuragen Corp. (MM)
19/05/200921:15Edgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)NASDAQ:CRGNCuragen Corp. (MM)
23/04/200917:03PR Newswire (US)/C O R R E C T I O N -- CuraGen Corporation/NASDAQ:CRGNCuragen Corp. (MM)
23/04/200912:30PR Newswire (US)CuraGen Reports First Quarter 2009 Financial ResultsNASDAQ:CRGNCuragen Corp. (MM)
10/03/200922:06Edgar (US Regulatory)Annual Report (10-K)NASDAQ:CRGNCuragen Corp. (MM)
27/02/200912:30PR Newswire (US)CuraGen Announces Board of Director ChangesNASDAQ:CRGNCuragen Corp. (MM)
18/02/200912:30PR Newswire (US)CuraGen's Board of Directors to Evaluate Strategic InitiativesNASDAQ:CRGNCuragen Corp. (MM)
29/01/200912:30PR Newswire (US)CuraGen Reports Fourth Quarter 2008 Financial Results; Provides Milestone and Financial Guidance for First Half of 2009NASDAQ:CRGNCuragen Corp. (MM)
15/01/200919:33Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)NASDAQ:CRGNCuragen Corp. (MM)
05/11/200812:30PR Newswire (US)CuraGen to Present at the Rodman & Renshaw Annual Global Investment ConferenceNASDAQ:CRGNCuragen Corp. (MM)
03/11/200812:45PR Newswire (US)CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with MetastNASDAQ:CRGNCuragen Corp. (MM)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CRGN

La tua Cronologia

BIT
UC1H28
Unicredit Bank
BIT
P1S5Z7
BNP Paribas Issuance
COIN
7UST
Lucky7
BIT
P1RRI2
BNP Paribas Issuance
LSE
0O2X
Immsi
COIN
JBCOEUR
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network